Evaluation of Kaletra Therapy Over the Long-term

CompletedOBSERVATIONAL
Enrollment

284

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Human Immunodeficiency Virus
Interventions
DRUG

Lopinavir/Ritonavir (Kaletra)

3 capsules 2xdaily or 2 tablets 2xdaily Kaletra

Trial Locations (90)

10117

Site Ref # / Investigator 27660, Berlin

Site Ref # / Investigator 27937, Berlin

Site Ref # / Investigator 52973, Berlin

10243

Site Reference ID/Investigator# 27629, Berlin

10439

Site Ref # / Investigator 27651, Berlin

Site Ref # / Investigator 27912, Berlin

Site Reference ID/Investigator# 27544, Berlin

10551

Site Reference ID/Investigator# 27567, Berlin

10589

Site Ref # / Investigator 27929, Berlin

10707

Site Ref # / Investigator 52971, Berlin

Site Ref # / Investigator 53468, Berlin

10777

Site Ref # / Investigator 27965, Berlin

Site Reference ID/Investigator# 27547, Berlin

Site Reference ID/Investigator# 27552, Berlin

Site Reference ID/Investigator# 27562, Berlin

10961

Site Ref # / Investigator 52984, Berlin

13347

Site Ref # / Investigator 27639, Berlin

Site Ref # / Investigator 52970, Berlin

15232

Site Ref # / Investigator 52983, Frankfurt

18057

Site Ref # / Investigator 27649, Rostock

20099

Site Ref # / Investigator 27931, Hamburg

Site Ref # / Investigator 27982, Hamburg

Site Ref # / Investigator 47114, Hamburg

Site Ref # / Investigator 47115, Hamburg

Site Reference ID/Investigator# 27551, Hamburg

Site Reference ID/Investigator# 27634, Hamburg

20146

Site Ref # / Investigator 30864, Hamburg

Site Ref # / Investigator 5348, Hamburg

Site Reference ID/Investigator# 27546, Hamburg

20246

Site Ref # / Investigator 28032, Hamburg

Site Ref # / Investigator 52969, Hamburg

Site Ref # / Investigator 53467, Hamburg

20354

Site Ref # / Investigator 52980, Hamburg

26121

Site Ref # / Investigator 27988, Oldenburg

Site Reference ID/Investigator# 27563, Oldenburg

33100

Site Ref # / Investigator 27939, Paderborn

40237

Site Ref # / Investigator 28056, Düsseldorf

41061

Site Ref # / Investigator 28104, Mönchengladbach

Site Ref # / Investigator 52981, Mönchengladbach

42277

Site Ref # / Investigator 27961, Wuppertal

44137

Site Ref # / Investigator 27704, Dortmund

Site Ref # / Investigator 27947, Dortmund

Site Ref # / Investigator 52968, Dortmund

47259

Site Reference ID/Investigator# 27558, Duisburg

47800

Site Ref # / Investigator 27905, Krefeld

48149

Site Ref # / Investigator 27648, Münster

Site Reference ID/Investigator# 27568, Münster

49076

Site Ref # / Investigator 27637, Osnabrück

Site Ref # / Investigator 27943, Osnabrück

Site Ref # / Investigator 52974, Osnabrück

50674

Site Ref # / Investigator 28060, Cologne

Site Ref # / Investigator 52978, Cologne

50679

Site Ref # / Investigator 27932, Cologne

Site Ref # / Investigator 52979, Cologne

50931

Site Ref # / Investigator 48233, Cologne

Site Ref # / Investigator 52985, Cologne

Site Ref # / Investigator 53464, Cologne

52062

Site Ref # / Investigator 27706, Aachen

Site Ref # / Investigator 52972, Aachen

53840

Site Ref # / Investigator 52976, Troisdorf

55116

Site Ref # / Investigator 27902, Mainz

Site Reference ID/Investigator# 27543, Mainz

56065

Site Ref # / Investigator 53466, Koblenz

Site Reference ID/Investigator# 27555, Koblenz

60311

Site Ref # / Investigator 27928, Frankfurt

Site Ref # / Investigator 52967, Frankfurt

67063

Site Ref # / Investigator 27948, Ludwigshafen

Site Ref # / Investigator 52977, Ludwigshafen

70197

Site Ref # / Investigator 27647, Stuttgart

Site Ref # / Investigator 28047, Stuttgart

Site Ref # / Investigator 28048, Stuttgart

Site Reference ID/Investigator# 27631, Stuttgart

76135

Site Ref # / Investigator 27641, Karlsruhe

Site Ref # / Investigator 27964, Karlsruhe

Site Reference ID/Investigator# 27561, Karlsruhe

79106

Site Reference ID/Investigator# 27565, Freiburg im Breisgau

80337

Site Ref # / Investigator 27949, Munich

Site Reference ID/Investigator# 27553, Munich

80801

Site Ref # / Investigator 27926, Munich

Site Ref # / Investigator 53462, Munich

90419

Site Ref # / Investigator 52982, Nuremberg

90762

Site Reference ID/Investigator# 27566, Fürth

D-10243

Site Ref # / Investigator 27909, Berlin

Site Ref # / Investigator 47113, Berlin

09113

Site Reference ID/Investigator# 27574, Chemnitz

D-90762

Site Ref # / Investigator 53465, Fürth

04107

Site Ref # / Investigator 27906, Leipzig

Site Ref # / Investigator 52975, Leipzig

Site Ref # / Investigator 53463, Leipzig

D-18057

Site Reference ID/Investigator# 27569, Rostock

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY

NCT01083810 - Evaluation of Kaletra Therapy Over the Long-term | Biotech Hunter | Biotech Hunter